FOX BIZ NEWS: Gilead to buy Immunomedics in $21B deal
Baca Juga
Gilead to buy Immunomedics in $21B deal
Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the companies said on Sunday in a statement.
0 Response to "FOX BIZ NEWS: Gilead to buy Immunomedics in $21B deal"
Post a Comment